Else Nutrition Holdings Inc (OTCMKTS:BABYF) on August 29, 2022, announced commencing the Canadian brick and mortar rollout in the month, in collaboration with Canadian-owned retail chain London Drugs.
Trading Data
On Monday, BABYF stock up 2.17% to $0.6308 with more than 240.70K shares, compared to volume of 185.69K shares. The stock moved within a range of $0.5501 – 0.6700 after opening trade at $0.5501.
Following Recent Online Launch Else Nutrition Debuts Its Canadian B&M Retail Rollout – Now Available at Pharmacy Chain London Drugs In 36 Markets Across Western Canada
Else’s Plant-Based Nutrition for Kids and Toddlers is available for purchase in London Drugs stores and would be available across 73 stores in Western Canada. With pharmacy retail stores in 36 major markets across Alberta, Saskatchewan, British Columbia, and Manitoba, the partnership enables Else Nutrition access to parents buying products for children.
Hamutal Yitzhak, CEO, and Co-Founder of Else Nutrition said that the launch of Canadian retail with an amazing partner like London Drugs is a strategically sound initiative. The CEO added that foraying into the Canadian marketplace introduces the brand to a vibrant and healthy-minded consumer base in the West.
The CEO added that London Drugs’ large-format shelves across British Columbia, Saskatchewan, Alberta, and Manitoba will facilitate Else Nutrition to provide better nutritional solutions for children.
Founded in Vancouver in 1945, London Drugs has stores in over 35 major markets throughout Alberta, Saskatchewan, British Columbia, and Manitoba. It also provides full-service cosmetics, computer department furniture, cameras, and hi-tech electronics. London Drugs serves more than 45 million customers every year and is a staple Canadian retail.
Key Quote
“Launching our Canadian retail rollout with an outstanding partner such as London Drugs is an exciting, and strategically sound initiative for Else,” said Hamutal Yitzhak, CEO and Co-Founder of Else Nutrition. “Entering the Canadian marketplace in Western Canada via London Drugs, introduces our brand to a vibrant and healthy-minded consumer-base in the West while acting as a springboard into greater Canada,” she continued.
Technical Data
BABYF stock is trading above the 20-Day and 50-Day Moving averages of $0.60 and $0.55 respectively. However, the stock is trading below the 200-Day moving average of $0.90. The company has a total market capitalization of $66.23 million.
